ZBNA
MRNA icon

Zions Bancorporation, National Association’s Moderna MRNA Stock Holding History

Zions Bancorporation, National Association’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.8K Sell
925
-101
-10% -$5.23K ﹤0.01% 509
2026
Q1 		$52.1K Sell
1,026
-3,942
-79% -$184K ﹤0.01% 528
2025
Q4 		$147K Buy
4,968
+4,797
+2,805% +$130K 0.01% 472
2025
Q3 		$4.42K Buy
171
+41
+32% +$1.14K ﹤0.01% 750
2025
Q2 		$3.59K Sell
130
-95
-42% -$2.5K ﹤0.01% 767
2025
Q1 		$6.38K Buy
+225
New +$7.98K ﹤0.01% 720

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Zions Bancorporation, National Association's MRNA Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its Moderna (MRNA) stake by 9.8% in Q2 2026, selling an estimated $5.23K and leaving 925 shares worth $64.8K. The position accounts for ﹤0.01% of the portfolio, ranked #509.

Zions Bancorporation, National Association first reported a position in MRNA in Q1 2025 and has held it in 6 quarters since. The position peaked at $147K in Q4 2025. 362 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Zions Bancorporation, National Association held 925 shares of Moderna worth $64.8K as of Q2 2026.
  • Zions Bancorporation, National Association sold 101 Moderna shares in Q2 2026, an estimated $5.23K.
  • Moderna made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #509 holding.
  • Zions Bancorporation, National Association first reported a position in Moderna in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's Moderna position peaked at $147K in Q4 2025.
  • 362 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.